|
2025 Conference Publication Comparative accuracy and reliability of handheld versus cart-based ultrasound in assessing inflammatory bowel disease activityKhaing, M. M., Fernandes, R. G., An, Y. K., Baraty, B., Bryant, R., Ghaly, S., Smith, R. L., Srinivasan, A., Hay, K. and Begun, J. (2025). Comparative accuracy and reliability of handheld versus cart-based ultrasound in assessing inflammatory bowel disease activity. 20th Congress of ECCO, Berlin, Germany, 19-22 February 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjae190.0834 |
|
2025 Conference Publication Clinical outcomes and predictive factors differ in acute severe ulcerative colitis for East Asian and Western patientsKim, E. S., Lee, H. S., Kim, D. H., Kim, H. S., Park, S. H., Kim, K. O., Jang, B., Kim, D. S., Lee, Y. J., Song, E. M., Kim, S. J., Lee, J., Yang, C. H., Sagami, S., Kobayashi, T., Mak, J., Liu, J., Cao, Q., Lin, W. C., Wei, S. C., Rice, K., An, Y. K., Begun, J., Ruddick-Collins, L., Fernandes, R. G., Gilmore, R., Vasudevan, A., Zhang, J., Brownson, A. ... Garg, M. (2025). Clinical outcomes and predictive factors differ in acute severe ulcerative colitis for East Asian and Western patients. OXFORD: OXFORD UNIV PRESS. doi: 10.1093/ecco-jcc/jjae190.0082 |
|
2025 Conference Publication Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trialPudipeddi, A., Lin, H., Paramsothy, S., Kariyawasam,, Paramsothy, R., Ghaly, S., Haifer, C., An, Y. K., Begun, J., Connor, S., Corte, C., Ward, M., De Cruz, P., Fung, C., Redmond, D., Chan, W., Mourad, F., Kermeen, M. and Leong, R. (2025). Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial. 20th Congress of ECCO, Berlin, Germany, 19-22 February 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjae190.0928 |
|
2025 Conference Publication Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration studyKim, S. J., Kim, D. H., Park, S. H., Kim, K. O., Jang, B., Kim, D. S., Lee, Y. J., Song, E. M., Lee, H. S., Kim, E. S., Yang, C. H., Sagami, S., Kobayashi, T., Mak, J., Liu, J., Cao, Q., Lin, C. C., Lin, W. C., Hsu, W. G., Wei, S. C., Rice, K., An, Y. K., Begun, J., Ruddick-Collins, L., Fernandes, R. G., Robert, G., Vasudevan, A., Zhang, J., Brownson, A. ... Garg, M. (2025). Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study. 20th Congress of ECCO, Berlin, Germany, 19-22 February 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjae190.0401 |
|
2025 Conference Publication Geographic disparities in healthcare utilisation in people with inflammatory bowel disease, Crohn's colitis cure data insights programSu, W. K., Wilson, W., Ng, W., Su, H., Forbes, A., Walker, G., Kim, A., Giles, E., Lawrance,, Dutt, S., Brett, L., An, Y. K., Lynch, K., Connor, S. J. and Andrews, J. M. (2025). Geographic disparities in healthcare utilisation in people with inflammatory bowel disease, Crohn's colitis cure data insights program. 20th Congress of ECCO, Berlin, Germany, 19-22 February 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjae190.0145 |
|
2025 Conference Publication Handheld ultrasound devices are an accurate alternative to cart-based ultrasound for IBD disease activity assessmentFernandes, R., Swe, E., Khaing, M. M., Gilmore, R., Khoo, E., An, Y. K. and Begun, J. (2025). Handheld ultrasound devices are an accurate alternative to cart-based ultrasound for IBD disease activity assessment. 20th Congress of ECCO, Berlin, Germany, 19-22 February 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjae190.1349 |
|
2025 Conference Publication The real-world use of intravenous and subcutaneous Vedolizumab in IBD across Australia and New Zealand, Crohn’s Colitis Cure Data Insight’s ProgramSu, W. K., Wilson, W., Wark, G., Ghaly, S., Lynch, K., Lawrance, I., Walker, G., Forbes, A., Brett, L., An, Y. K., Connor, S. J. and Andrews, J. M. (2025). The real-world use of intravenous and subcutaneous Vedolizumab in IBD across Australia and New Zealand, Crohn’s Colitis Cure Data Insight’s Program. 20th Congress of ECCO, Berlin, Germany, 19-22 February 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjae190.0777 |
|
2025 Conference Publication Correlation of biochemical, endoscopic and histologic endpoints in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trialPudipeddi, A., Dhanji, P., Paramsothy, S., Kariyawasam, V., Paramsothy, R., Ghaly, S., Haifer, C., An, Y. K., Begun, J., Connor, S., Corte, C., Ward, M., De Cruz, P., Fung, C., Redmond, D., Chan, W., Mourad, F., Kermeen, M. and Leong, R. (2025). Correlation of biochemical, endoscopic and histologic endpoints in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial. 20th Congress of ECCO, Berlin, Germany, 19-22 February 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjae190.0431 |
|
2025 Conference Publication Consistency and Quality of Inflammatory Bowel Disease care in Australasia; Towards Benchmarking, Crohn’s Colitis Cure Data Insight’s ProgramSu, W. K., McNamara, J., Wilson, W., Wark, G., Lynch, K., Su, H., Forbes, A., Lawrance, I., An, Y. K., Dutt, S., Brett, L., Walker, G., Andrews, J. M., Connor, S. J. and Ghaly, S. (2025). Consistency and Quality of Inflammatory Bowel Disease care in Australasia; Towards Benchmarking, Crohn’s Colitis Cure Data Insight’s Program. 20th Congress of ECCO, Berlin, Germany, 19-22 February 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjae190.0054 |
|
2025 Conference Publication Janus Kinase Inhibitors for the Management of Acute Severe Ulcerative Colitis: A Multicentre StudyGilmore, R., Fernandes, R., Chin, S., Con, D., De Cruz, P., Demase, K., Sparrow, M., Thin, L., Baker, J., Venugopal, K., Lucas, S., Garg, M., Loebenstein, M., Nguyen, A., Moore, G., Tandon, B., Bryant, R., MacFarlane, K., Lynch, K., Abdul, S., Subhaharan, D., Mohsen, W., Haig, A., Day, M., White, L., Begun, J. and An, Y. K. (2025). Janus Kinase Inhibitors for the Management of Acute Severe Ulcerative Colitis: A Multicentre Study. 20th Congress of ECCO, Berlin, Germany, 19-22 February 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjae190.1203 |
|
2024 Conference Publication Endotoxemia As Possible Cause of Inflammatory Bowel Diseases-Associated AnemiaBisht, Kavita, An, Yoon-Kyo, Shatunova, Svetlana, Wang, Ran, Barbier, Valerie, Giri, Rabina, Amiss, Anna, Tang, Yifu, Alexander, Kylie, Millard, Susan, Winkler, Ingrid G., Pettit, Allison, Begun, Jakob and Levesque, Jean-Pierre (2024). Endotoxemia As Possible Cause of Inflammatory Bowel Diseases-Associated Anemia. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-193349 |
|
2024 Conference Publication Documented variation in inflammatory bowel disease care in Australasia : Crohn's Colitis Cure (CCC) data insights programSu, Wai Kin, Mcnamara, Jack, Pipicella, Joseph, Wilson, William, Ghaly, Simon, Cabaero, Aura Gesha, Walker, Gareth, Forbes, Angela, Su, Heidi, Brett, Laurel, Dutt, Shoma, An, Yoon-Kyo, Lawrance, Ian, Lynch, Kate, Andrews, Jane and Connor, Susan J. (2024). Documented variation in inflammatory bowel disease care in Australasia : Crohn's Colitis Cure (CCC) data insights program. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Efficacy of combination vedolizumab and upadacitinib treatment in refractory inflammatory bowel disease: a case seriesSwe, Ei Phyu Phyu, Gilmore, Robert, Murali, Amrutha, Etchegaray, Amirah, Fernandes, Richard, An, Yoon-Kyo and Begun, Jakob (2024). Efficacy of combination vedolizumab and upadacitinib treatment in refractory inflammatory bowel disease: a case series. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitisKhoo, Emi, Amiss, Anna, Lindsay, Niamh, Fernandes, Richard, Gilmore, Robert, Ding, John Nik, Connor, Susan J., Bryant, Robert, White, Lauren, Mohsen, Waled, Leong, Rupert, Ardalan, Zaid, Croft, Anthony, De Cruz, Peter, Lynch, Kate, An, Yoon-Kyo, Holtmann, Gerald and Begun, Jakob (2024). Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Exploring a novel score to assess the patient perceived burden of disease in Crohn's disease and ulcerative colitis: Crohn's Colitis Cure (CCC) data insights programSu, Wai Kin, Gu, Bonita, Pipicella, Joseph, Wilson, William, Kim, Andrew, Wark, Gabrielle, Giles, Edward, Walker, Gareth, Forbes, Angela, Su, Heidi, Dutt, Shoma, An, Yoon-Kyo, Lawrance, Ian, Lynch, Kate, Connor, Susan J. and Andrews, Jane (2024). Exploring a novel score to assess the patient perceived burden of disease in Crohn's disease and ulcerative colitis: Crohn's Colitis Cure (CCC) data insights program. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Dose escalated therapy improving outcomes in inflammatory bowel disease: Crohn's Colitis Cure (CCC) data insights programSu, Wai Kin, Wilson, William, Ng, Watson, Whittaker, Clair, Giles, Edward, Walker, Gareth, Forbes, Angela, Lawrance, Ian, Dutt, Shoma, Lynch, Kate, Brett, Laurel, An, Yoon-Kyo, Connor, Susan J. and Andrews, Jane (2024). Dose escalated therapy improving outcomes in inflammatory bowel disease: Crohn's Colitis Cure (CCC) data insights program. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Post operative recurrence and surgical outcomes following Crohn's ileocolic resections in Australia (PORSCIA study)Giddings, Hugh, Ng, Kheng-Seong, Solomon, Michael, Arzivian, Arteen, Haifer, Craig, Lin, Huiyu, Pappas, Christian, Clark, David, Deacon, Anthony, Radford-Smith, Graham, Ebrahimi, Nargus, Wu, Ann, Lewis, Mark, Lim, Roscoe, Zhang, Jennifer, Vasudevan, Abhinav, Demase, Kathryn, Karp, Jadon, Fernandes, Richard, An, Yoon-Kyo, Ng, Zi Qin, Mackenzie, Scott, Thin, Lena, Greeve, Tessa, Moore, Gregory, Ghaly, Simon and Australia And New Zealand Inflammatory Bowel Disease Consortium, Crohn’s Colitis Cure (CCCURE) (2024). Post operative recurrence and surgical outcomes following Crohn's ileocolic resections in Australia (PORSCIA study). Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14–16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication The real-world use of five aminosalicylate treatment for ulcerative colitis: Crohn's Colitis Cure (CCC) data insights programSu, Wai Kin, Wilson, William, Pipicella, Joseph, Haifer, Craig, Williams, Astrid-Jane, Lynch, Kate, Forbes, Angela, Walker, Gareth, Schultz, Michael, Lawrance, Ian, An, Yoon-Kyo, Brett, Laurel, Connor, Susan J. and Andrews, Jane (2024). The real-world use of five aminosalicylate treatment for ulcerative colitis: Crohn's Colitis Cure (CCC) data insights program. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Janus kinase inhibitors for the management of acute severe ulcerative colitis: An Australian multicentre studyGilmore, Robert, Fernandes, Richard, Subhaharan, Deloshaan, Mohsen, Waled, Thin, Lena, Chin, Simone, Con, Danny, De Cruz, Peter, Demase, Kathryn, Sparrow, Miles P., Lucas, Sarah, Garg, Mayur, Bryant, Robert, Segal, Jonathan, Christensen, Britt, Begun, Jakob and An, Yoon-Kyo (2024). Janus kinase inhibitors for the management of acute severe ulcerative colitis: An Australian multicentre study. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitisKhoo, Emi, Amiss, Anna, Ding, Nik S., Bryant, Robert V., Mohsen, Waled, Connor, Susan J., Leong, Rupert, Croft, Anthony, Lynch, Kate D., Sparrow, Miles, De Cruz, Peter, An, Yoon-Kyo, Holtmann, Gerald J. and Begun, Jakob (2024). Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis. Digestive Disease Week (DDW) 2024, Washington, DC, United States, 18-21 May 2024. Philadelphia, PA, United States: Elsevier. doi: 10.1016/s0016-5085(24)00988-0 |
